Coronavirus channel feed

Covid-19 roundup: Con­va­les­cent plas­ma flops in UK tri­al; New York Gov. An­drew Cuo­mo seeks to pur­chase vac­cines di­rect­ly from Pfiz­er

5 years ago

Covid-19 roundup: Hack­ers start re­leas­ing 'ma­nip­u­lat­ed' Covid-19 vac­cine docs; Ex-FDA com­mish David Kessler to re­place Mon­cef Slaoui as Op­er­a­tion Warp Speed chief — re­port

5 years ago

Covid-19 roundup: Alex­ion's C5 in­hibitor Ul­tomiris miss­es the PhI­II bar; Lon­za in wait­ing game to use in­gre­di­ents in Mod­er­na vac­cine

5 years ago

J&J on track to roll out sin­gle-shot Covid-19 vac­cine in March, Paul Stof­fels con­firms, al­though man­u­fac­tur­ing de­lays raise ques­tions

5 years ago

Covid-19 roundup: Re­gen­eron scores $2.6B US sup­ply deal for an­ti­body cock­tail; Brazil­ian re­searchers walk back ef­fi­ca­cy rate for Sino­vac's can­di­date

5 years ago

Mon­cef Slaoui to step down from Op­er­a­tion Warp Speed in a month — re­port

5 years ago

Covid-19 roundup: Trump ad­min­is­tra­tion plan­ning to speed up shots; EMA to re­view As­traZeneca/Ox­ford vac­cine

5 years ago

Covid-19 roundup: Pfiz­er, BioN­Tech set new pro­duc­tion quo­ta for vac­cine at 2B dos­es in 2021; New da­ta show IL-6 in­hibitor could be ef­fec­tive treat­ment af­ter all

5 years ago

Covid-19 roundup: Pfiz­er, BioN­Tech study sug­gest vac­cine works against vari­ants; Re­searchers say Sino­vac's vac­cine is 78% ef­fec­tive

5 years ago

Covid-19 roundup: Cure­Vac finds big vac­cine part­ner in Bay­er; Slaoui will stay on as Biden con­sul­tant

5 years ago

Covid-19 roundup: EMA rec­om­mends Mod­er­na vac­cine for au­tho­riza­tion; Wood­cock re­turns to FDA as Hahn ad­vi­sor — re­ports

5 years ago

Mod­er­na inks deal for over­seas Covid-19 vac­cine fin­ish­ing work as Eu­ro­pean ap­proval hangs in bal­ance

5 years ago
Manufacturing

Covid-19 roundup: FDA all but re­jects changes to au­tho­rized vac­cine plans; Is­rael ap­proves Mod­er­na's vac­cine as coun­tries race to get shots in arms

5 years ago

Covid-19 roundup: In­ovio nabs $3 mil­lion and a de­vel­op­ment part­ner for its vac­cine that's still on par­tial hold; Slaoui pro­pos­es halv­ing Mod­er­na vac­cine dos­es as dis­tri­b­u­tion lags

5 years ago

As­traZeneca/Ox­ford score first vote of con­fi­dence as UK au­tho­rizes their Covid-19 vac­cine

5 years ago
FDA+

Covid-19 roundup: Mod­er­na of­fers vac­cine to work­ers, con­trac­tors and board mem­bers; Claim­ing 79% vac­cine ef­fi­ca­cy, Sinopharm shoots for full Chi­na OK

5 years ago

EU reg­u­la­tor says As­traZeneca ap­proval not im­mi­nent, even as Pas­cal So­ri­ot teas­es stronger da­ta

5 years ago
Pharma

Covid-19 roundup: Sino­vac pulls back from a promised PhI­II da­ta re­veal, rais­ing ques­tions about ef­fi­ca­cy

5 years ago

Warp Speed bets $356M to mass man­u­fac­ture a Mer­ck drug for se­vere Covid-19

5 years ago
Deals

Covid-19 roundup: US and Pfiz­er strike deal for 100M more dos­es; NIH and part­ners cut crit­i­cal­ly ill pa­tients out of blood thin­ner tri­al

5 years ago

Kiniksa whiffs on ef­fi­ca­cy try­ing to re­pur­pose an RA pro­gram for Covid-19, but spins sur­vival 'trend­s' as a pos­i­tive

5 years ago
R&D

Covid-19 roundup: Pfiz­er/BioN­Tech/Mod­er­na test vac­cines against new UK vari­ant; Ocu­gen strikes deal for US rights to PhI­II vac­cine

5 years ago

Covid-19 roundup: Pfiz­er/BioN­Tech vac­cine on verge of EU au­tho­riza­tion; Cure­Vac launch­es PhI­II tri­al in health­care work­ers

5 years ago

Covid-19 roundup: EU opts in­to 80M more Mod­er­na vac­cine dos­es; Boehringer In­gel­heim takes its an­ti­bod­ies in­to the clin­ic

5 years ago
First page Previous page 35363738394041 Next page Last page
A service from the Financial Times